FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2020386657> ?p ?o ?g. }

• W2020386657 endingPage "312" @default.
• W2020386657 startingPage "285" @default.
• W2020386657 abstract "Annals of the New York Academy of SciencesVolume 103, Issue 1 p. 285-312 THE MAST CELL, ITS AMINES, AND TUMOR GROWTH IN RODENTS AND MAN K. G. Scott, K. G. Scott Department of Radiology and The Radioactivity Research Center, University of California Medical Center, Sun Francisco, Calif.Search for more papers by this author K. G. Scott, K. G. Scott Department of Radiology and The Radioactivity Research Center, University of California Medical Center, Sun Francisco, Calif.Search for more papers by this author First published: February 1963 https://doi.org/10.1111/j.1749-6632.1963.tb53705.xCitations: 12AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Scott, K. G., W. L. Bostick, M. B. Shimkin & J. G. Hamilton. 1949. Distribution of globulin-bound thyroid fractions of iodine in normal and tumorous animals after intravenous administration using radioiodine as a tracer. Cancer. 2 (4): 692– 696. 2 Scott, K. G. & R. S. Stone. 1950. Tumor-host studies II. Increased concentration of tagged iodotyrosines in the gastrointestinal tract of rats bearing tumors. Cancer. 3 (4): 722– 724. 3 Scott, K. G. & R. S. Stone. 1951. Tumor-host studies III. Alteration of thyroid, skin, blood, and tumor uptake of I131-tagged diiodotyrosine in rats by transplanted tumors. Cancer. 4 (2): 345– 352. 4 Scott, K. G. & C. T. Peng. 1955. Tumor-host studies. The physiological and pharmacological action of an iodide-trapping substance formed in tumor-bearing animals. Univ. Calif. Publ. Pharmacol. 2 (22): 345– 376. 5 Scott, K. G., W. A. Reilly & G. L. Searle. 1960. I131 plasma and thyroid levels in cancer and control patients. Cancer. 13 (6): 1261– 1264. 6 Reilly, W. A., H. L. Helwig & K. G. Scott. 1956. Blood-volume measurements in cancer using the Cr51 red-blood-cell tagging method. Cancer. 9 (2): 273– 276. 7 Moore, S. & W. H. Stein. 1954. Procedures for the chromatographic determination of amino acids on four per cent cross-linked sulfonated polystyrene resins. J. Biol. Chem. 211 (2): 893– 906. 8 Riley, J. F. & G. B. West. 1953. The presence of histamine in tissue mast cells. J. Physiol. 120: 528– 537. 9 Riley, J. F. & G. B. West. 1955. Mast cell and histamine profiles in the skin of various species. J. Physiol. 130: 28P. 10 Riley, J. F. & G. B. West. 1955. Histamine liberation in the rat and mouse. Arch. Intern. Pharmacodyn. 102: 304– 313. 11 Riley, J. F. & G. B. West. 1955. Tissue mast cells. Studies with a histamine-liberator of low toxicity (compound 48/80). J. Pathol. Bacteriol. 69: 269– 282. 12 West, G. B. 1957. 5-Hydroxytryptamine, tissue mast cells and skin oedema. Intern. Arch. Allergy Appl. Immunol. 10: 257– 275. 13 Benditt, E. P., R. L. Wong, M. Arase & E. Roeper. 1955. 5-Hydroxytryptamine in mast cells. Proc. Soc. Exptl. Biol. Med. 90: 303– 304. 14 Holmgren, H. & O. Wilander. 1937. Beitrage zur Kenntnis der Chimie und Function der Ehrlichschen Mastzellen. Z. Zellforsch Mikroskop. Anat. 42: 242– 278. 15 Padawer, J. 1957. Studies on mammalian mast cells. Trans. N. Y. Acad. sci. 19: 690– 713. 16 Scheline, R. R. & E. G. Scott. 1958. Mast cell disruption and I131 distribution in the rat. Cancer Res. 18 (8): 932– 937. 17 Fawcett, D. W. 1954. Cytological and pharmacological observations on the release of histamine by mast cells. J. Exptl. Med. 100: 217– 224. 18 Scott, K. G., R. R. Scheline & R. S. Stone. 1958. Mast cells and sarcoma growth in the rat. Cancer. Res. 18 (8): 927– 931. 19 Korton, S. & E. J. de Beer. 1955. Effect of some antibiotics on rat mast cells in vitro. Arch. Intern. Pharmacodyn. 102: 352– 358. 20 Bushby, S. R. M. & A. F. Green. 1955. The release of histamine by polymyxin B and polymyxin E. Brit. J. Pharmacol. 10: 215– 218. 21 Norton, S. 1954. Quantitative determination of mast cell fragmentation by compound 48/80. Brit. J. Pharmacol. 9: 494– 497. 22 Paton, W. D. M. 1957. Histamine release by compounds of simple chemical structure. Pharmacol. Rev. 9: 269– 328. 23 Bhattacharya, B. E. & G. P. Lewis. 1956. Comparison of the effect of reserpine and 48/80 on the histamine and 5-hydroxytryptamine in mast cells of rats. J. Physiol. 133: 10P– 11P. 24 Bhattacharya, B. K. & Lewis, G. P. 1956. The release of 5-hydroxytryptamine by histamine liberators. Br. it. J. Pharmacol. 11: 202– 208. 25 Bhattacharya, B. K. & G. P. Lewis. 1956. The effects of reserpine and compound 48/80 on the release of amines from the mast cells of rats. Brit. J. Pharmacol. 11: 411– 416. 26 Parratt, J. R. & G. B. West. 1957. Release of 5-hydroxytryptamine and histamine from tissues of the rat. J. Physiol. 137: 179– 192. 27 Bland, J. E. 1956. Disturbance of Body Fluids. Pp. 6– 15. Saunders. Philadelphia , Pa . 28 Gismondo, P. 1952. (Histamine of blood in women with uterine myofibroma). Giorn. Ostet. Ginecol. 14: 313– 325. Abstr. 1952. Chem. Abstr. 46: 2676. 29 Shimkin, M. B., H. R. Biebman, B. V. A. Low-Beer, P. M. Wheeler & F. R. Goetzel. 1951. Blood histamine in myelogenous leukemia. Cancer. 4: 570– 578. 30 Shimkin, M. B., L. Sapirstein, F. R. Goetzel, P. M. Wheeler & N. I. Berlin. 1948-1949. J. Nat. Cancer Inst. 9: 379– 387. 31 Thiersh, J. B. 1947. Histamine and histaminase in chronic myeloid leukemia of man; I. histamine in blood of chronic myeloid leukemia. Australian. J. Exptl. Biol. Med. Sci. 25: 73– 77. 32 Valentine, W. N., M. L. Pearce & J. S. Lawrence. 1950. Studies on histamine content of blood with special reference to leukemia, leukemoid reactions, and leukocytosis. Blood. 5: 623– 647. 33 Kelemen, E., G. Bickich, J. Borbola & B. Tanos. 1953. Clinical investigations on histamine of leukaemic granulocytes. Acta. Haematol. 9: 171– 184. 34 Bickich, G., J. Borbola, B. Tanos & E. Kelemen. 1953. Histamine content of granulocytes, as possible characteristic of myelocytic leukaemia. Acta Med. Acad. Sci. Hung. 4: 17– 34. 35 Lemon, H. M., B. S. Walker, M. M. D. Reynolds & H. H. Wotiz. 1954. Medical progress, biochemistry of human cancer. New Engl. J. Med. 251: 937– 944. 36 Scott, K. G. & R. S. Stone. 1959. The anti-tumor action of lysergic acid derivatives and their serotonin-blocking effect as reflected by the I131 distribution in rats. Cancer Res. 19 (7): 783– 787. 37 Daniels, A. E. & K. G. Scott. Comparative effectiveness of twenty lysergic acid derivatives in blocking serotonin. In preparation. 38 Kimura, E. T., P. R. Young & R. K. Richards. 1960. Pharmacologic properties of N-p-chloro-benzhydryl-N'-methyl-homopiperazine dihydrochloride (Homochlorcyclizine; SA-97), a serotonin antagonist. J. Allergy. 31 (3): 237– 247. 39 Rowley, D. A. & E. P. Benditt. 1956. 5-Hydroxytryptamine and histamine as mediators of the vascular injury produced by agents which damage mast cells in rats. J. Exptl. Med. 103: 399– 411. 40 Sparrow, E. M. & D. L. Wilhelm. 1957. Species differences in susceptibility to capillary permeability factors: histamine, 5-HT, 48/80. J. Physiol. 137: 51– 66. 41 Cerletti, A. & W. Doepfner. 1958. Comparative study on the serotonin antagonism of amide derivatives of lysergic acid and of ergot alkaloids. J. Pharmacol. Exptl. Therap. 122: 124. 42 Love, W. D. & G. E. Burch. 1953. A comparison of K42, RB86, and Ce134 as tracers of potassium in the study of cation metabolism of human erythrocytes in vitro. J. Lab. Clin. Med. 41: 351– 362. 43 Solomon, A. K. 1952. The permeability of the human erythrocyte to sodium and potassium. J. Gen. Physiol. 36: 57– 110. 44 Shanes, A. M. 1955. Electrolytes in biological systems.: 134. American physiological Society. Washington , D. C. . 45 Prankerd, T. A. J. 1961. The Red Cell. P. 48. Blackwell Scientific Publications. Oxford , England . 46 Scott, K. G. & M. B. Daniels. 1956. The relationship between I131 metabolism, tumor growth, and regression. Cancer Res. 16 (8): 784– 787. 47 Corbascio, A. N. 1960. Action of long-chain polymers on kidney juxtaglomerular cells and connective tissue mast cells. Circulation Res. 8 (2): 390– 398. 48 Demopoulos, H., G. Kaley & B. W. Zweifach. 1961. Response of granular juxtaglomerular cells and tissue mast cells in various experimental states. Circulation Res. 9 (4): 845– 850. 49 Braun-Menendez, E. 1956. Pharmacology of renin and hypertensin. Pharmacol. Rev. 8 (1): 25– 55. 50 Tobian, L. 1960. Interrelationship of electrolytes, juxtaglomerular cells and hypertension. Physiol. Rev. 40 (2): 280– 312. 51 Page, I. H. & F. M. Bumpus. 1961. Angiotensin. Physiol. Rev. 41 (2): 331– 390. 52 Shetlar, M. R., J. V. Foster, K. H. Kelly, C. L. Shetlar, R. S. Bryan & M. R. Everett. 1949. The serum polysaccharide level in malignancy and in other pathological conditions. Cancer Res. 9: 515. 53 Boyland, E., L. O. Butler & B. E. Conway. 1951. The electrophoretic behaviour of normal and pathological human sera in relation to the polarographic serum test for cancer. Brit. J. Cancer. 5: 235– 243. 54 Darcey, D. A. 1960. A quantitative study of a serum protein associated with tissue growth. Values found in tumor-bearing rats. Brit. J. Cancer. 14 (3): 534– 546. 55 Beaton, G. H., A. E. Selby, M. J. Veen & A. M. Wright. 1961. Starch gel electrophoresis of rat serum proteins, II. Slow α2-globulin and other serum proteins in pregnant, tumor-bearing and young rats. J. Biol. Chem. 236 (7): 2005– 2008. 56 Almquist, P. O. & E. Lausing. 1957. A study of serum glycoproteins in cancer. Scand. J. Clin. Lab. Invest. 9: 179– 189. 57 Swanson, C. P. 1960. The Cell. Prentice-Hall. Englewood Cliffs , N. J . Citing Literature Volume103, Issue1Mast Cells and BasophilsFebruary 1963Pages 285-312 ReferencesRelatedInformation" @default.
• W2020386657 created "2016-06-24" @default.
• W2020386657 creator A5044235485 @default.
• W2020386657 date "2006-12-15" @default.
• W2020386657 modified "2023-09-23" @default.
• W2020386657 title "THE MAST CELL, ITS AMINES, AND TUMOR GROWTH IN RODENTS AND MAN" @default.
• W2020386657 cites W1505476665 @default.
• W2020386657 cites W1553854484 @default.
• W2020386657 cites W1973460694 @default.
• W2020386657 cites W1986090706 @default.
• W2020386657 cites W1995503256 @default.
• W2020386657 cites W1997852224 @default.
• W2020386657 cites W1998509734 @default.
• W2020386657 cites W2003852183 @default.
• W2020386657 cites W2010207171 @default.
• W2020386657 cites W2011720990 @default.
• W2020386657 cites W2015926819 @default.
• W2020386657 cites W2021025336 @default.
• W2020386657 cites W2028441589 @default.
• W2020386657 cites W2045685668 @default.
• W2020386657 cites W2054782124 @default.
• W2020386657 cites W2056311471 @default.
• W2020386657 cites W2057711150 @default.
• W2020386657 cites W2059536407 @default.
• W2020386657 cites W2065320438 @default.
• W2020386657 cites W2084905980 @default.
• W2020386657 cites W2096733541 @default.
• W2020386657 cites W2104381441 @default.
• W2020386657 cites W2134270329 @default.
• W2020386657 cites W2136814822 @default.
• W2020386657 cites W2144391656 @default.
• W2020386657 cites W2157140500 @default.
• W2020386657 cites W2324754427 @default.
• W2020386657 cites W2422690743 @default.
• W2020386657 cites W4243224462 @default.
• W2020386657 cites W68838113 @default.
• W2020386657 doi "https://doi.org/10.1111/j.1749-6632.1963.tb53705.x" @default.
• W2020386657 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/13992558" @default.
• W2020386657 hasPublicationYear "2006" @default.
• W2020386657 type Work @default.
• W2020386657 sameAs 2020386657 @default.
• W2020386657 citedByCount "19" @default.
• W2020386657 countsByYear W20203866572015 @default.
• W2020386657 crossrefType "journal-article" @default.
• W2020386657 hasAuthorship W2020386657A5044235485 @default.
• W2020386657 hasConcept C203014093 @default.
• W2020386657 hasConcept C2779655021 @default.
• W2020386657 hasConcept C2779726688 @default.
• W2020386657 hasConcept C502942594 @default.
• W2020386657 hasConcept C86803240 @default.
• W2020386657 hasConceptScore W2020386657C203014093 @default.
• W2020386657 hasConceptScore W2020386657C2779655021 @default.
• W2020386657 hasConceptScore W2020386657C2779726688 @default.
• W2020386657 hasConceptScore W2020386657C502942594 @default.
• W2020386657 hasConceptScore W2020386657C86803240 @default.
• W2020386657 hasIssue "1" @default.
• W2020386657 hasLocation W20203866571 @default.
• W2020386657 hasLocation W20203866572 @default.
• W2020386657 hasOpenAccess W2020386657 @default.
• W2020386657 hasPrimaryLocation W20203866571 @default.
• W2020386657 hasRelatedWork W1991837449 @default.
• W2020386657 hasRelatedWork W2014623953 @default.
• W2020386657 hasRelatedWork W2016555102 @default.
• W2020386657 hasRelatedWork W2032492283 @default.
• W2020386657 hasRelatedWork W2046196124 @default.
• W2020386657 hasRelatedWork W2065208221 @default.
• W2020386657 hasRelatedWork W2070820421 @default.
• W2020386657 hasRelatedWork W2426190722 @default.
• W2020386657 hasRelatedWork W4290244422 @default.
• W2020386657 hasRelatedWork W4298845329 @default.
• W2020386657 hasVolume "103" @default.
• W2020386657 isParatext "false" @default.
• W2020386657 isRetracted "false" @default.
• W2020386657 magId "2020386657" @default.
• W2020386657 workType "article" @default.